{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:33:15Z","timestamp":1790728395248,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neuroscience.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T12:40:29Z","timestamp":1539607229000},"page":"319-332","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans"],"prefix":"10.1016","volume":"393","author":[{"given":"Simona Denise","family":"Frederiksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Warfvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2018.10.004_b0005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/awt369","article-title":"Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38","volume":"137","author":"Amin","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s10194-018-0861-3","article-title":"Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine","volume":"19","author":"Amin","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.pain.2012.01.005","article-title":"mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system","volume":"153","author":"Amrutkar","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00309843","article-title":"Nerve fibres and their terminals of the dura mater encephali of the rat","volume":"175","author":"Andres","year":"1987","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0035","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0040","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/823493","article-title":"Serotonin receptors in hippocampus","volume":"2012","author":"Berumen","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ar.20975","article-title":"Immunohistochemical localization of substance P And cholecystokinin in the dorsal root ganglia and spinal cord of the bottlenose dolphin (Tursiops truncatus)","volume":"293","author":"Bombardi","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2018.10.004_b0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10072-009-0050-x","article-title":"Redefining primary headaches","volume":"30","author":"Bonavita","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0055","first-page":"219","article-title":"Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels","volume":"50","author":"Bouchelet","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1369\/jhc.2010.956920","article-title":"Controls for immunocytochemistry: an update","volume":"59","author":"Burry","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0333102414527648","article-title":"Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains","volume":"34","author":"Burstein","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jemt.20130","article-title":"GFAP immunoreactivity and transcription in trigeminal and dental tissues of rats and transgenic GFP\/GFAP mice","volume":"65","author":"Byers","year":"2004","journal-title":"Microsc Res Tech"},{"issue":"Suppl 4","key":"10.1016\/j.neuroscience.2018.10.004_b0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/head.12601","article-title":"Triptans in the acute treatment of migraine: a systematic review and network meta-analysis","volume":"55","author":"Cameron","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/head.12372","article-title":"CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine","volume":"54","author":"Cernuda-Morollon","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: implications for clinical management","volume":"17","author":"Charles","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2011.10.055","article-title":"Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion","volume":"202","author":"Csati","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2011.11.058","article-title":"Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion \u2013 interaction with the sensory system","volume":"1435","author":"Csati","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0100","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awq159","article-title":"Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers","volume":"133","author":"De Felice","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"VPAC and PAC receptors: from ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2018.10.004_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase-by-phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s10194-015-0555-z","article-title":"Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study","volume":"16","author":"Edvinsson","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bcp.12618","article-title":"CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment","volume":"80","author":"Edvinsson","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/head.12656","article-title":"The journey to establish CGRP as a migraine target: a retrospective view","volume":"55","author":"Edvinsson","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","article-title":"PACAP and its role in primary headaches","volume":"19","author":"Edvinsson","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J Pain"},{"issue":"Suppl 15","key":"10.1016\/j.neuroscience.2018.10.004_b0150","first-page":"33","article-title":"Treatment of cluster headache: clinical trials, design and results","volume":"15","author":"Ekbom","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0155","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ejn.13486","article-title":"Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide","volume":"45","author":"Farajdokht","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(12)70047-9","article-title":"Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study","volume":"11","author":"Farkkila","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","article-title":"Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials","volume":"22","author":"Ferrari","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0170","article-title":"Perivascular neurotransmitters: regulation of cerebral blood flow and role in primary headaches","volume":"271678x17747188","author":"Frederiksen","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0175","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0333102413517776","article-title":"Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia","volume":"34","author":"Greco","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0333102416639517","article-title":"Part II: biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients","volume":"37","author":"Guo","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/01.WNL.0000110312.36809.7F","article-title":"Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice","volume":"62","author":"Hall","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.brainresrev.2010.04.009","article-title":"Satellite glial cells in sympathetic and parasympathetic ganglia: in search of function","volume":"64","author":"Hanani","year":"2010","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-018-0855-1","article-title":"Discovery of PACAP and its receptors in the brain","volume":"19","author":"Hirabayashi","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0200","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(01)02645-2","article-title":"5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase","volume":"909","author":"Hou","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","article-title":"PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor","volume":"48","author":"Jansen-Olesen","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10194-017-0822-2","article-title":"PACAP and its receptors in cranial arteries and mast cells","volume":"19","author":"Jansen-Olesen","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0225","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","article-title":"Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia","volume":"13","author":"Knutsson","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00702-016-1539-0","article-title":"Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting","volume":"123","author":"Kollewe","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0240","first-page":"97","article-title":"Cytoarchitectonic study of the trigeminal ganglion in humans","volume":"86","author":"Krastev","year":"2013","journal-title":"Clujul Med"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0082(01)00021-1","article-title":"Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus","volume":"66","author":"Lazarov","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0250","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution","volume":"507","author":"Lennerz","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0255","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Specific marker expression and cell state of Schwann cells during culture in vitro","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-017-0746-x","article-title":"Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72)","volume":"18","author":"Lukacs","year":"2017","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-015-0575-8","article-title":"Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage","volume":"16","author":"Lundblad","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0270","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.0953-816x.2001.01586.x","article-title":"Colocalization of CGRP with 5-HT1B\/1D receptors and substance P in trigeminal ganglion neurons in rats","volume":"13","author":"Ma","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0275","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/ejn.13667","article-title":"Phenotypic change in trigeminal ganglion neurons associated with satellite cell activation via extracellular signal-regulated kinase phosphorylation is involved in lingual neuropathic pain","volume":"46","author":"Mikuzuki","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0280","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0306-4522(93)90018-B","article-title":"Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence","volume":"57","author":"Moller","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0285","first-page":"1041","article-title":"Trigeminal Autonomic Cephalalgias","volume":"21","author":"Newman","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0290","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1526-4610.2012.02247.x","article-title":"Spontaneous trigeminal allodynia in rats: a model of primary headache","volume":"52","author":"Oshinsky","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-016-0545-0","article-title":"Botulinum toxin: pharmacology and therapeutic roles in pain states","volume":"20","author":"Patil","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40064-015-0957-z","article-title":"OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm","volume":"4","author":"Pedraza","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0305","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/toxins4111196","article-title":"Emerging opportunities for serotypes of botulinum neurotoxins","volume":"4","author":"Peng Chen","year":"2012","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0310","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1756285614562419","article-title":"The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine","volume":"8","author":"Reuter","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-2982.2004.00683.x","article-title":"Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats","volume":"24","author":"Reuter","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0320","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10072-016-2568-z","article-title":"The use of onabotulinum toxin A (Botox((R))) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study","volume":"37","author":"Russo","year":"2016","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0325","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrneurol.2016.143","article-title":"New strategies for the treatment and prevention of primary headache disorders","volume":"12","author":"Schuster","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0330","article-title":"Challenges in developing drugs for primary headaches","author":"Schytz","year":"2016","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s10194-016-0664-3","article-title":"Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets","volume":"17","author":"Steinberg","year":"2016","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0340","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10194-016-0624-y","article-title":"Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats","volume":"17","author":"Sufka","year":"2016","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0345","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/2211068215586977","article-title":"Characterization of bovine serum albumin blocking efficiency on epoxy-functionalized substrates for microarray applications","volume":"21","author":"Sun","year":"2016","journal-title":"J Lab Autom"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","article-title":"Migraine and neuropeptides","volume":"52","author":"Tajti","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0355","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","article-title":"Mechanisms of action of the 5-HT1B\/1D receptor agonists","volume":"59","author":"Tepper","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0360","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","article-title":"Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy","volume":"60","author":"Tfelt-Hansen","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11940-017-0463-4","article-title":"Anti-CGRP monoclonal antibodies: the next era of migraine prevention?","volume":"19","author":"Tso","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0370","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0333102413483931","article-title":"Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients","volume":"33","author":"Tuka","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0380","first-page":"269","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0385","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ejn.12799","article-title":"Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses","volume":"41","author":"Vogl","year":"2015","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-018-0850-6","article-title":"PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma","volume":"19","author":"Waschek","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2017.03.011","article-title":"Supradural inflammatory soup in awake and freely moving rats induces facial allodynia that is blocked by putative immune modulators","volume":"1664","author":"Wieseler","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.10.004_b0400","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bmcl.2015.12.103","article-title":"New approaches to treating pain","volume":"26","author":"Wolkerstorfer","year":"2016","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218306651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218306651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T12:37:43Z","timestamp":1542803863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218306651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":80,"alternative-id":["S0306452218306651"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.10.004","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}